These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20131611)

  • 1. Improved preparation and identification of aristolochic acid-DNA adducts by solid-phase extraction with liquid chromatography-tandem mass spectrometry.
    Gao H; Guo F; Feng F; Yin J; Song M; Wang H
    J Environ Sci (China); 2009; 21(12):1769-76. PubMed ID: 20131611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.
    Chan W; Zheng Y; Cai Z
    J Am Soc Mass Spectrom; 2007 Apr; 18(4):642-50. PubMed ID: 17208007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
    Guo L; Wu H; Yue H; Lin S; Lai Y; Cai Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):153-8. PubMed ID: 21177145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthesis and mass spectrometric analysis of aristolochic acid-deoxyguanosine adducts].
    Ji WX; Liu MX; Yang CD; Chen YP
    Yao Xue Xue Bao; 2008 Mar; 43(3):295-8. PubMed ID: 18630267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
    Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
    Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
    Schmeiser HH; Frei E; Wiessler M; Stiborova M
    Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive measurement of aristolochic acid-DNA adducts in urine samples from aristolochic acid-treated rats by liquid chromatography coupled tandem mass spectrometry: evidence for DNA repair by nucleotide-excision repair mechanisms.
    Leung EM; Chan W
    Mutat Res; 2014; 766-767():1-6. PubMed ID: 25847264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of aristolochic acid-derived DNA adducts in rat kidney and liver by using liquid chromatography-electrospray ionization mass spectrometry.
    Chan W; Yue H; Poon WT; Chan YW; Schmitz OJ; Kwong DW; Wong RN; Cai Z
    Mutat Res; 2008 Nov; 646(1-2):17-24. PubMed ID: 18812181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Quantification of aristolochic acids and their DNA adducts in mice kidney and liver by HPLC-MS/MS].
    Yang J; Jia ZX; Liu J; Li YT; Li Q; Su RB; Ma ZC; Yan XN; Qu BQ; Xiao HB
    Zhongguo Zhong Yao Za Zhi; 2020 Jun; 45(11):2634-2641. PubMed ID: 32627499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
    Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
    Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new approach for the sensitive determination of DNA adduct of aristolochic acid II by using high-performance liquid chromatography with fluorescence detection.
    Chan W; Poon WT; Chan YW; Wan KY; Cai Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):848-52. PubMed ID: 19249256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid.
    Broschard TH; Wiessler M; von der Lieth CW; Schmeiser HH
    Carcinogenesis; 1994 Oct; 15(10):2331-40. PubMed ID: 7955074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
    Broschard TH; Wiessler M; Schmeiser HH
    Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aristolactam I a metabolite of aristolochic acid I upon activation forms an adduct found in DNA of patients with Chinese herbs nephropathy.
    Stiborová M; Frei E; Breuer A; Bieler CA; Schmeiser HH
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):421-7. PubMed ID: 10445409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase.
    Stiborová M; Frei E; Sopko B; Sopková K; Marková V; Lanková M; Kumstýrová T; Wiessler M; Schmeiser HH
    Carcinogenesis; 2003 Oct; 24(10):1695-703. PubMed ID: 12869422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases.
    Martinek V; Kubickova B; Arlt VM; Frei E; Schmeiser HH; Hudecek J; Stiborova M
    Neuro Endocrinol Lett; 2011; 32 Suppl 1():57-70. PubMed ID: 22167209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2'-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry.
    Goodenough AK; Schut HA; Turesky RJ
    Chem Res Toxicol; 2007 Feb; 20(2):263-76. PubMed ID: 17305409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.
    Arlt VM; Wiessler M; Schmeiser HH
    Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.